Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00354835
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:49.150826+00:00
Published At
2017-07-25T00:00:00+00:00
Record Updated At
2023-01-31
Results Posted At
2017-07-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adult Rhabdomyosarcoma", "Childhood Alveolar Rhabdomyosarcoma", "Childhood Botryoid-Type Embryonal Rhabdomyosarcoma", "Childhood Embryonal Rhabdomyosarcoma", "Localized Childhood Soft Tissue Sarcoma", "Rhabdomyosarcoma", "Sarcoma", "Stage I Adult Soft Tissue Sarcoma AJCC v7", "Stage II Adult Soft Tissue Sarcoma AJCC v7", "Stage III Adult Soft Tissue Sarcoma AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-01-31"
protocolSection.identificationModule.nctId
"NCT00354835"
protocolSection.identificationModule.officialTitle
"Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-07-25"

Study condition terms

  • Adult Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Childhood Alveolar Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Childhood Botryoid-Type Embryonal Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Childhood Embryonal Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Localized Childhood Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage I Adult Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage II Adult Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Adult Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.